These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

795 related items for PubMed ID: 12670899

  • 1. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
    Yang B, Keshelava N, Anderson CP, Reynolds CP.
    Cancer Res; 2003 Apr 01; 63(7):1520-6. PubMed ID: 12670899
    [Abstract] [Full Text] [Related]

  • 2. Tirapazamine cytotoxicity for neuroblastoma is p53 dependent.
    Yang B, Reynolds CP.
    Clin Cancer Res; 2005 Apr 01; 11(7):2774-80. PubMed ID: 15814660
    [Abstract] [Full Text] [Related]

  • 3. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
    Anderson CP, Reynolds CP.
    Bone Marrow Transplant; 2002 Aug 01; 30(3):135-40. PubMed ID: 12189530
    [Abstract] [Full Text] [Related]

  • 4. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
    Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, Birrell GW, Peehl DM, Knox SJ.
    Cell Death Differ; 2002 Mar 01; 9(3):252-63. PubMed ID: 11859408
    [Abstract] [Full Text] [Related]

  • 5. Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids.
    Cuperus R, van Kuilenburg AB, Leen R, Bras J, Caron HN, Tytgat GA.
    Free Radic Biol Med; 2011 Sep 15; 51(6):1213-20. PubMed ID: 21741474
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX, Ogawa O, Kakehi Y.
    Int J Oncol; 2004 Jun 15; 24(6):1489-97. PubMed ID: 15138592
    [Abstract] [Full Text] [Related]

  • 7. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH, Park WH.
    Oncol Rep; 2009 Aug 15; 22(2):385-91. PubMed ID: 19578781
    [Abstract] [Full Text] [Related]

  • 8. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators.
    Batra S, Reynolds CP, Maurer BJ.
    Cancer Res; 2004 Aug 01; 64(15):5415-24. PubMed ID: 15289350
    [Abstract] [Full Text] [Related]

  • 9. Hepatocyte growth factor protects RPE cells from apoptosis induced by glutathione depletion.
    Jin M, Yaung J, Kannan R, He S, Ryan SJ, Hinton DR.
    Invest Ophthalmol Vis Sci; 2005 Nov 01; 46(11):4311-9. PubMed ID: 16249513
    [Abstract] [Full Text] [Related]

  • 10. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y.
    Biochem Biophys Res Commun; 2002 Mar 08; 291(4):861-7. PubMed ID: 11866444
    [Abstract] [Full Text] [Related]

  • 11. Ornithine decarboxylase prevents tumor necrosis factor alpha-induced apoptosis by decreasing intracellular reactive oxygen species.
    Liu GY, Hung YC, Hsu PC, Liao YF, Chang WH, Tsay GJ, Hung HC.
    Apoptosis; 2005 May 08; 10(3):569-81. PubMed ID: 15909119
    [Abstract] [Full Text] [Related]

  • 12. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC.
    Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674
    [Abstract] [Full Text] [Related]

  • 13. Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis.
    Anderson CP, Tsai JM, Meek WE, Liu RM, Tang Y, Forman HJ, Reynolds CP.
    Exp Cell Res; 1999 Jan 10; 246(1):183-92. PubMed ID: 9882527
    [Abstract] [Full Text] [Related]

  • 14. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
    Hu XM, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2003 Jul 10; 52(1):47-58. PubMed ID: 12750841
    [Abstract] [Full Text] [Related]

  • 15. Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine.
    Wouters BG, Delahoussaye YM, Evans JW, Birrell GW, Dorie MJ, Wang J, MacDermed D, Chiu RK, Brown JM.
    Cancer Res; 2001 Jan 01; 61(1):145-52. PubMed ID: 11196153
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine.
    Han YH, Kim SZ, Kim SH, Park WH.
    Int J Oncol; 2008 Jul 01; 33(1):205-13. PubMed ID: 18575767
    [Abstract] [Full Text] [Related]

  • 17. Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.
    Morales MC, Pérez-Yarza G, Nieto-Rementeria N, Boyano MD, Jangi M, Atencia R, Asumendi A.
    Anticancer Res; 2005 Jul 01; 25(3B):1945-51. PubMed ID: 16158929
    [Abstract] [Full Text] [Related]

  • 18. Apoptosis in arsenic trioxide-treated Calu-6 lung cells is correlated with the depletion of GSH levels rather than the changes of ROS levels.
    Han YH, Kim SH, Kim SZ, Park WH.
    J Cell Biochem; 2008 Jun 01; 104(3):862-78. PubMed ID: 18393359
    [Abstract] [Full Text] [Related]

  • 19. Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1.
    Wu D, Cederbaum AI.
    Alcohol Clin Exp Res; 2001 Apr 01; 25(4):619-28. PubMed ID: 11329505
    [Abstract] [Full Text] [Related]

  • 20. Regulation of apoptosis/necrosis execution in cadmium-treated human promonocytic cells under different forms of oxidative stress.
    Sancho P, Fernández C, Yuste VJ, Amrán D, Ramos AM, de Blas E, Susin SA, Aller P.
    Apoptosis; 2006 May 01; 11(5):673-86. PubMed ID: 16532269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.